SANDERS MACHELLE
Insider CIK 1718020 · RDUS Director · NOVN Director · FTRE Director · BCRX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| FTRE Fortrea Holdings Inc. | S Sale | 2026-08-03 | 2026-08-05 | 9,700 | $18.01 | $174.7K | 36,399 | SEC↗ |
| FTRE Fortrea Holdings Inc. | S Sale | 2026-08-03 | 2026-08-05 | 9,700 | $18.01 | $174.7K | 36,399 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2026-06-11 | 2026-06-15 | 33,540 | — | $0 | 33,540 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2026-06-11 | 2026-06-15 | 15,294 | — | $0 | 45,936 | SEC↗ |
| FTRE Fortrea Holdings Inc. | A Award deriv | 2026-06-10 | 2026-06-12 | 12,852 | — | $0 | 12,852 | SEC↗ |
| FTRE Fortrea Holdings Inc. | M Exercise deriv | 2026-06-10 | 2026-06-12 | 38,817 | — | $0 | 0 | SEC↗ |
| FTRE Fortrea Holdings Inc. | M Exercise | 2026-06-10 | 2026-06-12 | 38,817 | — | $0 | 46,099 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2025-11-13 | 2025-11-17 | 9,600 | $7.14 | $68.5K | 30,642 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2025-06-12 | 2025-06-16 | 27,181 | — | $0 | 27,181 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2025-06-12 | 2025-06-16 | 12,500 | — | $0 | 40,242 | SEC↗ |
| FTRE Fortrea Holdings Inc. | A Award deriv | 2025-06-10 | 2025-06-12 | 38,817 | — | $0 | 38,817 | SEC↗ |
| FTRE Fortrea Holdings Inc. | M Exercise deriv | 2025-05-14 | 2025-05-16 | 7,282 | — | $0 | 0 | SEC↗ |
| FTRE Fortrea Holdings Inc. | M Exercise | 2025-05-14 | 2025-05-16 | 7,282 | — | $0 | 7,282 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2024-06-17 | 2024-06-17 | 4,689 | $6.00 | $28.1K | 27,742 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2024-06-12 | 2024-06-14 | 49,933 | — | $0 | 49,933 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2024-06-12 | 2024-06-14 | 6,820 | — | $0 | 32,431 | SEC↗ |
| FTRE Fortrea Holdings Inc. | A Award deriv | 2024-05-14 | 2024-05-16 | 7,282 | — | $0 | 7,282 | SEC↗ |
| NOVN Novan, Inc. | S Sale | 2023-06-27 | 2023-06-27 | 11,553 | $0.41 | $4.7K | 25,248 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | S Sale | 2023-06-15 | 2023-06-15 | 4,000 | $7.98 | $31.9K | 25,611 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2023-06-13 | 2023-06-15 | 39,072 | — | $0 | 39,072 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2023-06-13 | 2023-06-15 | 16,745 | — | $0 | 29,611 | SEC↗ |
| NOVN Novan, Inc. | M Exercise deriv | 2023-06-07 | 2023-06-08 | 36,101 | — | $0 | 0 | SEC↗ |
| NOVN Novan, Inc. | M Exercise | 2023-06-07 | 2023-06-08 | 36,101 | — | $0 | 36,801 | SEC↗ |
| NOVN Novan, Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 103,092 | — | $0 | 103,092 | SEC↗ |
| RDUS Radius Health, Inc. | D To issuer deriv | 2022-08-15 | 2022-08-15 | 10,000 | $3.60 | $36.0K | 0 | SEC↗ |
| RDUS Radius Health, Inc. | D To issuer | 2022-08-15 | 2022-08-15 | 5,500 | $10.00 | $55.0K | 0 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2022-06-07 | 2022-06-09 | 30,022 | — | $0 | 30,022 | SEC↗ |
| NOVN Novan, Inc. | A Award deriv | 2022-06-07 | 2022-06-09 | 36,101 | — | $0 | 36,101 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2022-06-07 | 2022-06-09 | 12,866 | — | $0 | 12,866 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2022-02-08 | 2022-02-10 | 26,667 | — | $0 | 26,667 | SEC↗ |
| RDUS Radius Health, Inc. | A Award deriv | 2022-01-14 | 2022-01-25 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RDUS Radius Health, Inc. | A Award | 2022-01-14 | 2022-01-25 | 5,500 | — | $0 | 5,500 | SEC↗ |
| NOVN Novan, Inc. | A Award deriv | 2021-05-26 | 2021-05-28 | 8,923 | — | $0 | 8,923 | SEC↗ |
| NOVN Novan, Inc. | A Award deriv | 2021-05-04 | 2021-05-06 | 35,000 | — | $0 | 35,000 | SEC↗ |
| RDUS Radius Health, Inc. | A Award deriv | 2021-01-04 | 2021-01-05 | 30,000 | — | $0 | 30,000 | SEC↗ |
| NOVN Novan, Inc. | A Award deriv | 2020-07-28 | 2020-07-30 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NOVN Novan, Inc. | P Buy deriv | 2020-03-03 | 2020-03-05 | 7,000 | — | $0 | 7,000 | SEC↗ |
| NOVN Novan, Inc. | P Buy | 2020-03-03 | 2020-03-05 | 7,000 | — | $0 | 7,000 | SEC↗ |
| NOVN Novan, Inc. | A Award deriv | 2019-07-31 | 2019-08-02 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NOVN Novan, Inc. | A Award deriv | 2018-06-04 | 2018-06-07 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NOVN Novan, Inc. | A Award deriv | 2017-09-24 | 2017-09-26 | 19,240 | — | $0 | 19,240 | SEC↗ |